Clinical and bacteriologic observations on the proposed species, Enterobacter agglomerans (the Herbicola-Lathyri bacteria).
D000293:Adolescent; D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000494:pharmacology; D002512:Cephalothin / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000494:pharmacology; D004755:Enterobacteriaceae / Q000145:classification / Q000187:drug effects; D004756:Enterobacteriaceae Infections; D004885:Erwinia / Q000145:classification / Q000187:drug effects; D005260:Female; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011113:Polymyxins / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014552:Urinary Tract Infections / Q000209:etiology*; D014640:Vancomycin / Q000494:pharmacology; D014946:Wound Infection / Q000209:etiology*
D005839:Gentamicins; D011113:Polymyxins; D002701:Chloramphenicol; D014640:Vancomycin; D000667:Ampicillin; D013752:Tetracycline; D002512:Cephalothin; D013307:Streptomycin